Is Magnesium Good for High Cholesterol?

Magnesium supplements do not meaningfully lower total cholesterol, LDL cholesterol, or triglycerides in most people, according to meta-analyses of randomized controlled trials. The one consistent bright spot is a modest bump in HDL (the “good” cholesterol), but even that effect is small. The story gets more interesting, though, when you look at people who are already magnesium-deficient or who have elevated cholesterol going in, because the mineral appears to matter more in those specific situations than in the general population.

What the Clinical Trials Actually Show

The most recent large-scale analysis of randomized trials, an updated dose-response meta-analysis published in 2025, found no significant differences in total cholesterol, triglycerides, or LDL between people taking magnesium and those taking a placebo. The one exception was HDL cholesterol, which rose by a small but statistically significant amount, roughly 1.2 mg/dL, in the magnesium group.¹ To put that in context, an HDL increase of 1.2 mg/dL is real but tiny compared to what lifestyle changes or medications achieve. It is not the kind of shift that would move someone out of a risk category.

An earlier 2017 meta-analysis reached a similar conclusion, finding no significant effect of magnesium on total cholesterol, LDL, HDL, or triglycerides in either diabetic or non-diabetic individuals.² The fact that two independent meta-analyses, years apart and with different pools of trials, agree on the null result makes the conclusion fairly robust. If magnesium were a powerful cholesterol-lowering agent, it would have shown up by now.

The Exception for People With Already-Elevated Lipids

Where the picture shifts is in subgroup analyses. When researchers zoom in on people who already have high cholesterol or high triglycerides, magnesium supplementation does appear to lower LDL and triglycerides. A review of epidemiological and trial data noted that while the overall pooled results showed nothing significant, a subgroup of participants with existing hypercholesterolemia saw reductions in LDL, and those with elevated triglycerides saw triglyceride levels drop after supplementation.³ The implication is that magnesium’s effect on lipids depends on your metabolic starting point. If your cholesterol is already normal and your magnesium status is fine, adding a supplement probably will not change much. If your lipids are out of range and your magnesium is low, there may be a real benefit.

This finding also helps explain why observational studies consistently show a link between magnesium and cholesterol even when clinical trials in mixed populations come up empty. A systematic review of the crosstalk between magnesium and serum lipids found that people diagnosed with dyslipidemia had significantly lower magnesium levels compared to those with normal lipid profiles.⁴ The association is there. It just does not translate into a clean “take magnesium, lower cholesterol” recommendation for everyone.

How Magnesium Fits Into Cholesterol Biology

The reason researchers keep investigating magnesium and lipids, even after repeated null results in broad trials, is that the biological plausibility is solid. Magnesium is involved in regulating the same enzyme that statin drugs target: HMG-CoA reductase, which controls the rate-limiting step in cholesterol synthesis. Statins work by blocking that enzyme. Magnesium does not block it outright, but it is required by the enzyme that deactivates HMG-CoA reductase, making magnesium a natural regulator of the pathway rather than a pharmaceutical-style inhibitor.⁵ Think of it as a dimmer switch instead of an off switch.

On the triglyceride side, animal research has shown that magnesium deficiency impairs lipoprotein lipase, the enzyme responsible for clearing triglycerides from the blood. In magnesium-deficient rats, the activity of this enzyme dropped substantially, and triglycerides rose as a result.⁶ This helps explain why the subgroup effects are stronger in people who are deficient: if you already have enough magnesium, topping off the tank does not make the enzyme work faster, but running low genuinely impairs it.

Beyond the Numbers on a Lipid Panel

Cholesterol management is not just about how much LDL or total cholesterol is floating around in your blood. It also matters what happens to that LDL once it is there, and this is where magnesium’s role gets more interesting than its lukewarm effects on lipid panel numbers. Experimentally induced low magnesium levels accelerate atherosclerosis not only by raising LDL concentrations but also by promoting oxidative modification of LDL particles and fueling inflammation.⁷ Oxidized LDL is far more damaging to artery walls than regular LDL. It is the form that immune cells gobble up, leading to the fatty plaques that characterize heart disease.

Separately, laboratory research has shown that magnesium-containing compounds can inhibit LDL oxidation triggered by multiple pathways, including copper ions, endothelial cells, and enzymes involved in inflammation, at concentrations that are achievable in humans.⁸ This does not mean popping a magnesium pill directly shields your LDL from oxidation in the same way, but it adds to the biological rationale for keeping magnesium levels adequate when cardiovascular risk is a concern.

Magnesium supplementation has also been shown to reduce C-reactive protein, a key marker of systemic inflammation. A meta-analysis of trials found a significant drop in CRP levels following magnesium supplementation.⁹ Since chronic low-grade inflammation drives plaque formation and destabilization in blood vessels, lowering CRP is a meaningful benefit in its own right, even if the numbers on a standard lipid panel barely budge.

When Magnesium Deficiency Makes Cholesterol Worse

One of the more practical angles here involves people who are already low on magnesium without knowing it. Magnesium deficiency is common and often silent; routine blood panels do not typically include it, and serum levels can look normal even when the body’s stores are depleted. Certain populations are especially vulnerable. People with metabolic syndrome, for instance, tend to have lower magnesium levels in both their blood and their cells, and those with insulin resistance have even lower levels than those without it.¹⁰ Since metabolic syndrome already comes with elevated triglycerides and low HDL, magnesium depletion may be compounding the lipid problems rather than existing as a separate issue.

Magnesium is also closely tied to how the body handles insulin. It helps regulate insulin secretion and plays a role in how insulin receptors on cells respond to the hormone.¹¹ Insulin resistance itself drives up triglycerides and pushes down HDL, so addressing a magnesium shortfall could improve lipids indirectly by improving insulin sensitivity rather than by acting on cholesterol metabolism directly. This is one reason the subgroup effects in supplementation trials are more pronounced in people with metabolic disturbances.

Medications That Drain Magnesium and Raise Cholesterol

If you take a diuretic for blood pressure, you may be unknowingly setting yourself up for both magnesium depletion and worse cholesterol numbers. Both thiazide-type and loop diuretics promote urinary loss of magnesium, and a study of hypertensive patients on these drugs found a significant negative correlation between magnesium and triglycerides, total cholesterol, and LDL, along with a positive correlation between magnesium and HDL.¹² In plain terms, the patients with the lowest magnesium had the worst lipid profiles. This creates a frustrating loop: you take a diuretic for your blood pressure, it depletes your magnesium, and your cholesterol gets worse as a result. If your doctor has not checked your magnesium levels and you are on a diuretic, it is worth raising the question.

Proton-pump inhibitors (the heartburn drugs many people take long-term) are another well-known magnesium depleter. Anyone on chronic medications that affect mineral balance should be aware that their lipid panel might partly reflect a mineral gap rather than diet or genetics alone.

The Calcium-to-Magnesium Ratio

An underappreciated factor in cardiovascular risk is not just how much magnesium you get, but how much you get relative to calcium. A study of an Iranian health cohort found that a higher dietary calcium-to-magnesium ratio was associated with higher ten-year coronary risk, even after adjusting for other variables.¹³ This matters because many people supplement calcium (especially postmenopausal women concerned about bone density) without giving a thought to magnesium. The result can be a ratio that is tilted heavily toward calcium, which may offset some of the cardiovascular benefit magnesium would otherwise provide.

The ideal dietary ratio of calcium to magnesium is generally estimated at somewhere around 2:1, though the evidence on a precise cutoff is still evolving. If you are loading up on calcium through supplements or dairy without matching it with adequate magnesium from leafy greens, nuts, seeds, or a supplement, the imbalance itself could contribute to cardiovascular risk independent of any cholesterol effect.

Why Magnesium Intake Is Lower Than It Used to Be

A question worth asking is why magnesium deficiency is so widespread in the first place. Part of the answer is modern food systems. Magnesium content in fruits and vegetables has dropped over the last fifty years, and roughly 80% of the mineral is lost during food processing.¹⁴ That means even people who eat plenty of produce may not be getting what previous generations did from the same foods. Combine declining soil mineral content with diets heavy in refined grains and processed foods, and you get a large percentage of people worldwide falling short of their daily magnesium needs.

The recommended daily intake for adults in the United States is around 310 to 420 mg depending on age and sex. National dietary surveys consistently show that average intakes fall below these targets. You can get meaningful amounts from dark chocolate, almonds, spinach, pumpkin seeds, avocado, and black beans, but many people do not eat enough of these foods regularly. For those considering a supplement, magnesium citrate, glycinate, and taurate are generally well absorbed, while magnesium oxide, the cheapest and most common form on store shelves, has lower bioavailability and tends to cause more gastrointestinal side effects.

Practical Takeaways for People Watching Their Cholesterol

If you are taking magnesium specifically hoping to lower your LDL or total cholesterol, the trial evidence says it probably will not do that, at least not in a way that shows up on your next blood draw. Magnesium is not a substitute for statins or other lipid-lowering therapy in people who need those medications. Where it may help is at the margins: a modest HDL increase, reduced inflammation, better insulin sensitivity, and protection against the kind of LDL oxidation that actually damages arteries. These are genuine cardiovascular benefits even if they do not register as a dramatic change on a standard lipid panel.

The people most likely to see lipid improvements from magnesium are those who are deficient to begin with, particularly people with metabolic syndrome, type 2 diabetes, or those on medications that deplete magnesium. If you fall into one of those groups, correcting a magnesium shortfall could be one of the more impactful low-cost interventions available. Talk to your doctor about checking your levels, since standard blood panels often skip magnesium, and serum magnesium alone can miss intracellular depletion.

Hormonal Context and Magnesium Shifts

Magnesium levels are not static across a lifetime, and hormonal changes can meaningfully alter how much magnesium your body holds onto. Research on postmenopausal women has found that magnesium levels were inversely related to estrogen levels, meaning that as estrogen dropped after menopause, magnesium levels tended to rise to levels comparable to the early follicular phase in premenopausal women.¹⁵ This might seem like good news for postmenopausal magnesium status, but the relationship is complicated by the fact that menopause also tends to worsen the lipid profile, with LDL and total cholesterol rising. The interplay between shifting hormones, changing mineral balance, and worsening lipids means that a one-size-fits-all approach to magnesium supplementation does not capture the full picture.

For premenopausal women, fluctuations in estrogen across the menstrual cycle may also influence magnesium requirements, though the research here is thinner. The broader point is that magnesium needs and magnesium’s effects on metabolic markers are not uniform across populations or life stages. What works for a 35-year-old man may not be the relevant question for a 60-year-old woman on hormone therapy, and vice versa.

The Relationship Between Magnesium and Statin Use

Given that magnesium and statin drugs both interact with HMG-CoA reductase, researchers have explored whether magnesium supplementation might complement statin therapy. Chronic low magnesium has been flagged as a potential contributor to metabolic conditions that overlap heavily with the conditions statins treat, including insulin resistance, altered lipid metabolism, and low-grade inflammation.¹⁶ Some clinicians have speculated that correcting a magnesium deficit in statin users could improve the drug’s effectiveness or reduce side effects like muscle cramps, which are among the most common reasons people stop taking their statins. The evidence for this remains preliminary, but it is a reasonable area of inquiry given how many statin users also have low magnesium intake.

Statin-related muscle symptoms affect a substantial minority of users, and magnesium plays a well-established role in muscle function. Whether supplementation actually reduces these symptoms has not been proven in large trials, but individual clinicians report anecdotal improvement. If you are on a statin and experiencing muscle aches, mentioning magnesium to your prescriber is a low-risk conversation to have.